Dr. Charles Thomas recognized ASTRO’s 2019 grant awardees during the Research Spotlight session that also highlighted the research of prior grantees. #ASTRO19

Chelain - this picture hangs on my office wall - I’ll see what I can do.

Many congratulations to our deserving ASTRO Gold Medal winners. #ASTRO19

One special aspect about Radiation Research Society Meetings is its interdisciplinary nature‼️🤗🤗🤗🤗 Starting it off with radiation exposure and mitigation ... on the 🌚 moon☺️ #RadRes2024

A huge shoutout to our amazing #WomenWhoCurie board members & ASTRO CEO, Laura Thevenot, for their leadership & dedication to ASTRO. Just missing Geraldine Jacobson & Dr. Ng. #ASTRO24 Wendy Woodward MDPhD Malika Siker, MD Neha Vapiwala Chelsea C Pinnix MD PhD catheryn yashar SWRO WinC - AlinC (Women in Cancer - All in Cancer)

#radbio strength at #ASTRO24 presidential reception 💪 Celebrating well deserved ASTRO FASTRO recognition of Julie Schwarz & Brian Marples 👍👍🥂 #ASTRO24

#Radbio represent! Fun times with friends and colleagues #ASTRO2024 Henning Willers, MD, FASTRO @Bri

Paper and podcast now out from PARTIQol trial! No difference between PBT and IMRT with respect to bowel scores, urinary or sexual function, as well as disease outcomes including PFS. Some questions still remain re graded toxicity, DVH as discussed by Dr. Deville. #ASTRO24 #pcsm

Fantastic presentation by Kristin Higgins on LU005! Much to learn about immunotherapy with chemoRT and which subtypes may benefit most. The benefit of BID is one of the largest we have ever seen compared to high dose conventional daily RT, corroborating CONVERT and other studies.

Wrapping up the plenary, Sue Yom reports on interim results of NRG HN-005 where unfortunately both de-escalation arms resulted in inferior PFS (with HR>4!!!). Future efforts to de-intensification now have a high bar to overcome. #ASTRO24

👤 NRG-HN005 presented during plenary at #ASTRO2024 #radonc Sue Yom 1️⃣ Arm 1: 70 Gy + cisplatin - PFS 98.1% 2️⃣ Arm 2: 60 Gy + cisplatin - PFS 88.6% 3️⃣ Arm 3: 60 Gy + nivolamab - PFS 90.3% ➡️ SOC remains 70 Gy + cisplatin

Our field would not be the same without these two outstanding leaders in #RadOnc. So grateful for all the work they put in to make positive change for all patients. #ASTRO24 ASTRO #CHEDI

Congrats to our #ASTRO24 Fellows! 👏👏 astro.org/about-astro/re…

Julie Schwarz, MD, PhD, (Julie Schwarz), a Washington University Radiation Oncologist, is officially an ASTRO Fellow during the #ASTRO24 award ceremony featuring speaker Jeff Michalski, MD, FASTRO. @WashURadOnc 📸On left with Dr. Gay (@HiramGay), on right with Women Fellow

Congratulations to Dr. @Ying Xiao, a head of NRG physics, for designation to Fellow of ASTRO! The whole NRG Physics group is proud of you!!! ASTRO #ASTRO24

We’re having a great time meeting everyone at ASTRO24! There’s still time to come see us at Booth 1937 and speak with our team. #ASTRO24 #ASTRO2024 #nmsc #skincancertreatment #radiotherapy #radiantaura

Congrats Julie.

Congratulations to these brilliant women who are now Fellows of ASTRO ! Hats off to the class of 2024. 🎓🎓 astro.org/about-astro/re…

Honored to gavel in my new tenure as ASTRO Board Chair

With old colleague and superstar radiation biologist ⁦IU Radiation Oncology⁩ Marc Mendonca ⁦ASTRO⁩ 2024!